New Gene Therapy Company To Focus On Lentiviral Platforms – Pharmaceutical Processing
|
New Gene Therapy Company To Focus On Lentiviral Platforms
Pharmaceutical Processing Biotech company Vectalys has merged with FlashCell, a developer of non-integrating lentiviral delivered RNA treatments, to form Flash Therapeutics, a new privately held company developing gene and cell therapeutics. Flash Therapeutics intends to … |
